Linkage Biosciences Raises $2.1M in Series B Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Linkage Biosciences today announced it has raised $2.1 million in a Series B financing round.

The funds will be used to expand manufacturing capabilities, complete regulatory requirements in the US and Europe, and accelerate molecular tests to market, Zachary Antovich, CEO of Linkage, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.